Loading insider details...
Beta
Latest Form 4 (Jul 1, 2026): Sale of 56,019 AKBA shares, $62.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 1, 2026 | Akebia Therapeutics, Inc. (AKBA) | Sale | 56,019 | $62.2K |
| Feb 4, 2026 | Akebia Therapeutics, Inc. (AKBA) | Sale | 34,951 | $48.6K |
| Feb 3, 2026 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 204,000 | n/a |
| Jul 1, 2025 | Akebia Therapeutics, Inc. (AKBA) | Sale | 41,314 | $151.6K |
| Feb 4, 2025 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 194,900 | n/a |
| Jul 2, 2024 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 350,000 | n/a |
| Feb 6, 2024 | AVROBIO, Inc. (AVRO) | Exercise/Conversion | 40,084 | n/a |
| Jul 3, 2023 | AVROBIO, Inc. (AVRO) | Grant/Award | 70,000 | n/a |
| Feb 10, 2023 | AVROBIO, Inc. (AVRO) | Grant/Award | 160,333 | n/a |
| Dec 9, 2022 | AVROBIO, Inc. (AVRO) | Grant/Award | 221,000 | n/a |